Alzamend Neuro, Inc.ALZNNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank89
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
18.40%
↑ 102% vs avg
Percentile
P89
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-785.34%
Historical baseline
PeriodValue
202518.40%
20245.67%
2023-32.78%
2022-147.80%
2021-15.61%
2020-124.43%
201949.06%
2018-44.82%
2017-7561.12%
20160.00%